Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza
Claire Scott, Jayakanth Kankanala, Toshana L. Foster, Daniel Goldhill, Katie Simmons, Marieke Pingen, Matthew Bentham, Elizabeth Atkins, Eleni Loundras, Ruth Elderfield, Jolyon K. Claridge, Joseph Thompson, Peter R. Stilwell, Ranjitha Tathineni, Clive McKimmie, Paul Targett-Adams, Jason R. Schnell, Graham Cook, Wendy S. Barclay, Richard Foster, Stephen Griffin
bioRxiv 713636; doi: https://doi.org/10.1101/713636